Physician profile
Michael Patrick Hall
NPI 1265828404
$3,559.43
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $14.75 · 2021: $360 · 2022: $920 · 2023: $1,370 · 2024: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,019.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $630.72 | 2019-2024 | |
| Novo Nordisk INC | $568.31 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $230.38 | 2022-2024 | |
| Abbvie INC. | $225.14 | 2022-2024 | |
| Lilly USA, LLC | $203.57 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $196.71 | 2022 | |
| Axsome Therapeutics, INC. | $175.44 | 2022-2023 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.12 | 2022-2024 | Jardiance |
| Glaxosmithkline, LLC. | $150.47 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.46 | 2022-2024 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $99.27 | 2022-2024 | |
| Exact Sciences Corporation | $82.37 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $74.89 | 2022-2024 | Trintellix |
| Astellas Pharma US INC | $73.58 | 2021-2023 | Myrbetriq, Veozah |
| Daiichi Sankyo INC. | $61.57 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $49.26 | 2021-2023 | Gvoke Hypopen |
| Amgen INC. | $43.34 | 2021-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $40.61 | 2023-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $39.85 | 2019-2022 | |
| Abbott Laboratories | $36.57 | 2023-2024 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $33.08 | 2023 | Heplisav-B |
| Teva Pharmaceuticals USA, INC. | $29.15 | 2021 | |
| Dexcom, INC. | $25.67 | 2021 | |
| Nestle Healthcare Nutrition INC. | $20.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.52 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.17 | 2023 | Quviviq |
| Allergan, INC. | $16.42 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.33 | 2022 | |
| Corium, LLC | $13.98 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.93 | 2024 | Onpattro |
| Esperion Therapeutics, INC. | $13.71 | 2024 | Nexletol |
| Mylan Specialty L.P. | $13.50 | 2022 | |
| Merck Sharp & Dohme LLC | $13.03 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.97 | 2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $12.24 | 2022 | |
| Genentech USA, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.